From a molecular standpoint, it was observed that tumor cells with BRAF alterations may undergo senescence after an initial period of growth, suggesting that a subgroup of pediatric low-grade gliomas may exhibit decelerating growth kinetics over time [13]. The gene discussed is BRAF; the disease is low grade glioma.